Viewing Study NCT00159289



Ignite Creation Date: 2024-05-05 @ 11:53 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00159289
Status: WITHDRAWN
Last Update Posted: 2024-04-04
First Post: 2005-09-08

Brief Title: Endotoxin and Inflammatory Markers in Healthy Non-Smokers and Current Smokers Including Patients With Chronic Obstructive Pulmonary Disease COPD
Sponsor: Imperial College London
Organization: Imperial College London

Study Overview

Official Title: Effect of Endotoxin on Inflammatory Markers in Exhaled Breath Sputum Saliva and Nasal Lavage in Healthy Non-Smokers and Current Smokers Including Patients With COPD
Status: WITHDRAWN
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: No resources available
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary aim of this study is to investigate the effects of inhaled lipopolysaccharide endotoxin LPS on bronchial and alveolar exhaled nitric oxide NO and NO metabolites and other inflammatory markers and mediators in exhaled breath condensate induced sputum nasal lavage and mouthwash fluid in healthy non-smokers and current smokers including patients with chronic obstructive pulmonary disease COPD
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None